161 related articles for article (PubMed ID: 27236555)
1. Synthetic Cystine-Knot Miniproteins - Valuable Scaffolds for Polypeptide Engineering.
Avrutina O
Adv Exp Med Biol; 2016; 917():121-44. PubMed ID: 27236555
[TBL] [Abstract][Full Text] [Related]
2. Chemical synthesis, backbone cyclization and oxidative folding of cystine-knot peptides: promising scaffolds for applications in drug design.
Reinwarth M; Nasu D; Kolmar H; Avrutina O
Molecules; 2012 Oct; 17(11):12533-52. PubMed ID: 23095896
[TBL] [Abstract][Full Text] [Related]
3. Natural and engineered cystine knot miniproteins for diagnostic and therapeutic applications.
Kolmar H
Curr Pharm Des; 2011 Dec; 17(38):4329-36. PubMed ID: 22204431
[TBL] [Abstract][Full Text] [Related]
4. Cystine-knot peptides: emerging tools for cancer imaging and therapy.
Ackerman SE; Currier NV; Bergen JM; Cochran JR
Expert Rev Proteomics; 2014 Oct; 11(5):561-72. PubMed ID: 25163524
[TBL] [Abstract][Full Text] [Related]
5. Engineering knottins as novel binding agents.
Moore SJ; Cochran JR
Methods Enzymol; 2012; 503():223-51. PubMed ID: 22230571
[TBL] [Abstract][Full Text] [Related]
6. Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins.
Kolmar H
Curr Opin Pharmacol; 2009 Oct; 9(5):608-14. PubMed ID: 19523876
[TBL] [Abstract][Full Text] [Related]
7. Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins.
Kolmar H
FEBS J; 2008 Jun; 275(11):2684-90. PubMed ID: 18435757
[TBL] [Abstract][Full Text] [Related]
8. The cystine knot motif in toxins and implications for drug design.
Craik DJ; Daly NL; Waine C
Toxicon; 2001 Jan; 39(1):43-60. PubMed ID: 10936622
[TBL] [Abstract][Full Text] [Related]
9. Fragmentation follows structure: top-down mass spectrometry elucidates the topology of engineered cystine-knot miniproteins.
Reinwarth M; Avrutina O; Fabritz S; Kolmar H
PLoS One; 2014; 9(10):e108626. PubMed ID: 25303319
[TBL] [Abstract][Full Text] [Related]
10. Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles.
Kintzing JR; Cochran JR
Curr Opin Chem Biol; 2016 Oct; 34():143-150. PubMed ID: 27642714
[TBL] [Abstract][Full Text] [Related]
11. Oxidative folding of peptides with cystine-knot architectures: kinetic studies and optimization of folding conditions.
Reinwarth M; Glotzbach B; Tomaszowski M; Fabritz S; Avrutina O; Kolmar H
Chembiochem; 2013 Jan; 14(1):137-46. PubMed ID: 23229141
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial optimization of cystine-knot peptides towards high-affinity inhibitors of human matriptase-1.
Glotzbach B; Reinwarth M; Weber N; Fabritz S; Tomaszowski M; Fittler H; Christmann A; Avrutina O; Kolmar H
PLoS One; 2013; 8(10):e76956. PubMed ID: 24146945
[TBL] [Abstract][Full Text] [Related]
13. Targeting the tumor vasculature with engineered cystine-knot miniproteins.
Lui BG; Salomon N; Wüstehube-Lausch J; Daneschdar M; Schmoldt HU; Türeci Ö; Sahin U
Nat Commun; 2020 Jan; 11(1):295. PubMed ID: 31941901
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and MALDI-TOF Mass Spectrometric Characterization of a Novel Native and Recombinant Cystine Knot Miniprotein from Solanum tuberosum subsp. andigenum cv. Churqueña.
Cotabarren J; Tellechea ME; Tanco SM; Lorenzo J; Garcia-Pardo J; Avilés FX; Obregón WD
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495576
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer.
Kimura RH; Teed R; Hackel BJ; Pysz MA; Chuang CZ; Sathirachinda A; Willmann JK; Gambhir SS
Clin Cancer Res; 2012 Feb; 18(3):839-49. PubMed ID: 22173551
[TBL] [Abstract][Full Text] [Related]
16. Ultra-stable peptide scaffolds for protein engineering-synthesis and folding of the circular cystine knotted cyclotide cycloviolacin O2.
Leta Aboye T; Clark RJ; Craik DJ; Göransson U
Chembiochem; 2008 Jan; 9(1):103-13. PubMed ID: 18058973
[TBL] [Abstract][Full Text] [Related]
17. Engineering agatoxin, a cystine-knot peptide from spider venom, as a molecular probe for in vivo tumor imaging.
Moore SJ; Leung CL; Norton HK; Cochran JR
PLoS One; 2013; 8(4):e60498. PubMed ID: 23573262
[TBL] [Abstract][Full Text] [Related]
18. Engineered cystine-knot miniproteins for diagnostic applications.
Kolmar H
Expert Rev Mol Diagn; 2010 Apr; 10(3):361-8. PubMed ID: 20370592
[TBL] [Abstract][Full Text] [Related]
19. Allotides: Proline-Rich Cystine Knot α-Amylase Inhibitors from Allamanda cathartica.
Nguyen PQ; Luu TT; Bai Y; Nguyen GK; Pervushin K; Tam JP
J Nat Prod; 2015 Apr; 78(4):695-704. PubMed ID: 25832441
[TBL] [Abstract][Full Text] [Related]
20. Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta.
Sommerhoff CP; Avrutina O; Schmoldt HU; Gabrijelcic-Geiger D; Diederichsen U; Kolmar H
J Mol Biol; 2010 Jan; 395(1):167-75. PubMed ID: 19852971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
